IAM 90

IAM 90

IAM 90

Inside Shenzhen – China’s high-tech heartland

The southern city of Shenzhen and its surrounding environs are China’s Silicon Valley. For global patent market players, knowledge of this region is a must

Download

Features

Does the United States have the national strategy and infrastructure to establish a technological lead?

Re-establishing the quality, strength and predictability of the US patent system would make a major contribution to ensuring the nation’s leadership in a wide number of technology areas

1,000 US patent club 2018

Between them, the 346 entities named in the IAM/ktMINE US Patent 1,000 Club hold close to 50% of all active US patents

Choosing the right tools for better IP decisions

There are many tools designed to help IP owners in the value creation process, but selecting the right ones can be a tough task. Considering the key issues can help to simplify the process

Bigger than BlackBerry

Mark Kokes quit as BlackBerry’s IP head last year to go to work at a sprawling conglomerate owned by one of California’s richest men. Charged with monetising a huge, disparate portfolio, this new role could be his biggest challenge yet

Building an effective, business-focused patent portfolio

Businesses that want to maximise the value of their intellectual property must understand it will not just happen overnight. Instead, they must put in place proactive plans to manage the process – and that means starting even before patent applications are filed

China stakes its claim in the self-driving race for success

Self-driving car sales are expected to hit 21 million by 2035. No surprise then that both traditional car makers and leading technology companies are vying to be the first to release a fully autonomous vehicle

IAM benchmarking survey 2018

With close to 900 responses, the 2018 IAM benchmarking survey is the biggest we have carried out yet. The results reveal an IP market that is more international than ever before, but which has still to fully recover its mojo

The case for licensing biopharma patents after loss of exclusivity

Greater licensing of their secondary patents would not only generate additional income for many pharma companies but would also enable the industry to serve patients better and avoid political controversy

Roundtable

Is SEP licensing up to standard?

The landscape around SEP licensing has changed considerably in recent years thanks in large part to key court decisions. As courts and regulators around the world continue to frame the debate around SEPs, there is much for patent owners to consider

Data centre

IP-related statistics from the recent past

A selection of key IP facts and figures, as reported by IAM and other sources

Insights

A round-up of IP-related quotes, observations and opinions from the recent past …

Supreme Court shakes up the PTAB, while new USPTO head sends strong pro-patent signals

No one expected the Supreme Court to turn the US patent system upside down with Oil States – and it did not. But its SAS judgment issued on the same day could mean some big post-grant changes. Meanwhile, Andrei Iancu is exhibiting pro-patent inclinations

Columns

IP strategist: SMEs embrace intellectual property as an essential and integrated business function

Challenging the common misconception that patent protection is too complex and costly for small and medium-sized enterprises, recent European Patent Office case studies reveal that such companies are building success through their IP strategies

Intangible investor: US innovation policy: time for a makeover

America’s confused response to increased global competition and IP uncertainty is threatening its innovation leadership

IP lawyer: Beijing High Court upholds China’s first-ever SEP injunction

Iwncomm v Sony broke new ground in granting injunctive relief to a Chinese plaintiff. In confirming the decision, the Beijing High Court has staked out some interesting positions on exhaustion and contributory infringement

Unlock unlimited access to all IAM content